Issued Patents 2022
Showing 1–25 of 25 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11535615 | Heterocyclic compounds as immunomodulators | Neil Lajkiewicz, Liangxing Wu | 2022-12-27 |
| 11530218 | Spiro compounds as inhibitors of KRAS | Le Zhao, Xiaozhao Wang, Wenyu Zhu, Haolin Yin, Liangxing Wu | 2022-12-20 |
| 11530214 | Bicyclic heterocycles as FGFR inhibitors | Liang Lu, Chunhong He, Fenglei Zhang | 2022-12-20 |
| 11492354 | Indazole compounds and uses thereof | Alexander Sokolsky, Oleg Vechorkin, Anlai Wang, Qinda Ye | 2022-11-08 |
| 11472791 | Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors | Joshua Hummel, Jingwei Li, Zhenwu Li, Ding-Quan Qian, Liangxing Wu +8 more | 2022-10-18 |
| 11465981 | Heterocyclic compounds as immunomodulators | Liangxing Wu, Zhiyong Yu, Fenglei Zhang | 2022-10-11 |
| 11459329 | Imidazopyridazine and imidazopyridine compounds and uses thereof | Jun Pan, Jeremy Roach, Song Mei, Chunhong He, Liangxing Wu | 2022-10-04 |
| 11447494 | Tricyclic amine compounds as CDK2 inhibitors | Qinda Ye, Ken Mukai, Liangxing Wu | 2022-09-20 |
| 11440914 | Tricyclic amine compounds as CDK2 inhibitors | Qinda Ye, Neil Lajkiewicz, Ken Mukai, Liangxing Wu | 2022-09-13 |
| 11433071 | Heterocyclylamines as PI3K inhibitors | Yun-Long Li, Andrew P. Combs, Eddy W. Yue, Song Mei, Joseph Glenn +4 more | 2022-09-06 |
| 11427597 | Heteroaryl amide compounds as sting activators | Liangxing Wu, Neil Lajkiewicz | 2022-08-30 |
| 11427567 | Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors | Qinda Ye, Jingwei Li, Ken Mukai, Brandon Smith, Liangxing Wu +4 more | 2022-08-30 |
| 11414433 | Heterocyclic compounds as immunomodulators | Liangxing Wu, Kaijiong Xiao | 2022-08-16 |
| 11407749 | Heterocyclic compounds as immunomodulators | Liangxing Wu, Bo Shen, Jingwei Li, Zhenwu Li, Kai Liu +1 more | 2022-08-09 |
| 11406624 | Pyrazolopyridine compounds and uses thereof | Alexander Sokolsky, Oleg Vechorkin, Kai Liu, Jun Pan, Qinda Ye | 2022-08-09 |
| 11401279 | Pyrido[3,2-d]pyrimidine compounds as immunomodulators | Jingwei Li, Liangxing Wu | 2022-08-02 |
| 11401272 | Heterocyclic compounds as LSD1 inhibitors | Chunhong He, Zhenwu Li, Liangxing Wu, Fenglei Zhang | 2022-08-02 |
| 11384083 | Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors | Alexander Sokolsky, Sarah Winterton, Liangxing Wu | 2022-07-12 |
| 11339149 | Heterocyclic compounds as immunomodulators | Liangxing Wu, Jingwei Li, Chao Qi, Ding-Quan Qian, Fenglei Zhang | 2022-05-24 |
| 11299473 | Benzimidazole and indole compounds and uses thereof | Joshua Hummel, Minh Ngoc Nguyen, Alexander Sokolsky, Oleg Vechorkin, Qinda Ye | 2022-04-12 |
| 11261191 | Imidazotriaines and imidazopyrimidines as kinase inhibitors | Jincong Zhuo, Meizhong Xu, Chunhong He, Colin Zhang, Ding-Quan Qian +3 more | 2022-03-01 |
| 11247992 | Cyclopropylamines as LSD1 inhibitors | Liangxing Wu, Joel R. Courter, Chunhong He, Xiaozhao Wang, Fenglei Zhang | 2022-02-15 |
| 11242343 | Pyrazolopyridine compounds and uses thereof | Kai Liu, Jun Pan, Alexander Sokolsky, Oleg Vechorkin, Hai Fen Ye +1 more | 2022-02-08 |
| 11229631 | Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors | Chu-Biao Xue, Yun-Long Li, Hao Feng, Jun Pan, Anlai Wang +3 more | 2022-01-25 |
| 11214573 | Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors | David M. Burns, Jincong Zhuo | 2022-01-04 |